Japanese health and welfare officials agreed to reimburse healthcare providers for procedures using the TransEnterix (NYSE:TRXC) Senhance robot-assisted surgery device, the company said today. The reimbursement, which became effective yesterday, applies to 98 benign and malignant laparoscopic procedures across general, colorectal, gynecologic, bariatric and urologic surgeries. The reimbursement rates are equivalent to those provided in […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Philips close to sealing Carestream Health imaging IT deal
Royal Philips (NYSE:PHG) said today that it has completed its acquisition of Carestream Health’s imaging IT business in 26 of the 38 countries in which it operates. Philips said the purchase will expand its enterprise diagnostic informatics solutions, including productivity enhancement, imaging data management, and advanced visualization and analysis. The company expects to complete the […]
Teleflex ticks up on Q2 beats, raised outlook
Teleflex (NYSE:TFX) posted a swing to second-quarter black ink today, topped the consensus forecast for both sales and earnings and raised its top-line outlook for the rest of the year, sending share prices up on Wall Street today. The Wayne, Pa.-based medical device giant reported profits of $83.4 million, or $1.77 per share, on sales growth […]
Judge tosses 5,000 warming-device lawsuits filed against 3M
This story has been updated with a comment from Augustine Surgical and the plaintiffs’ attorneys. A federal judge has dismissed more than 5,000 lawsuits filed against 3M (NYSE:MMM) over its Bair Hugger patient warming system. The decision follows six years of litigation over claims that the warming system was responsible for infections suffered by patients […]
Integra Lifesciences picks up Arkis Biosciences
Integra LifeSciences (NSDQ:IART) this week acquired Arkis BioSciences and its line of neurosurgery devices for an undisclosed amount. Knoxville, Tenn.-based Arkis makes the CerebroFlo external ventricular drainage catheter that uses its Endexo anti-thrombus additive to prevent blood clots. “Neurocritical care is an important area of focus for Integra. We recently introduced our CereLink intracranial pressure monitor […]
Abiomed plunges on fiscal Q1 earnings miss, lowered outlook
Abiomed (NSDQ:ABMD) shares came under pressure today after the medical device maker reported fiscal first-quarter sales that missed the mark and lowered its top-line outlook on the rest of the year. Danvers, Mass.-based Abiomed posted profits of $88.9 million, or $1.93 per share, on sales of $207.7 million for the three months ended June 3o, […]
Could this soft, stretchable wearable help out kids?
Georgia Tech researchers are touting a wireless, wearable monitor made with stretchable electronics, saying it could be especially useful for babies and small children with skin sensitivities to conventional adhesive sensors with conductive gels. The 3-in.-wide wearable includes circuitry made of thin-film, mesh-like patterns of copper that are able to flex with the soft substrate. […]
Masimo Q2 results exceed expectations
Masimo (NSDQ:MASI) announced second-quarter results today that beat The Street, raising its guidance for the rest of the year. The Irvine, Calif.–based patient monitoring technology company reported profits of $44.9 million, or $0.79 per share, on sales of $229.7 million for the three months ended June 29, with net income up 2.4% and sales increasing 13.6% compared […]
Hologic beats The Street on Q3 earnings
Hologic (NSDQ:HOLX) reported third-quarter earnings this evening that beat the consensus forecast on Wall Street, raising its full-year guidance. The Marlborough, Mass.–based women’s health medtech company reported profits of $93.9 million, or $0.35 per share, on sales of $852.4 million for the three months ended June 29, for a bottom-line decrease of 16.8% and sales growth […]
Dexcom posts Street-beating Q2 earnings
Dexcom (NSDQ:DXCM) posted second-quarter results this evening that beat the consensus forecast on Wall Street, and raised its outlook for the rest of the year. The San Diego–based continuous glucose monitoring (CGM) technology company reported a loss of $10.5 million, or $0.12 per share, on sales of $336.4 million for the three months ended June 30. […]
Mylan agrees to settle SEC EpiPen probe for $30 million
Mylan (NSDQ:MYL) is nearing a $30 million settlement with the Securities and Exchange Commission (SEC) over an investigation involving the company’s EpiPen auto-injector and the Medicaid drug rebate program. The SEC probe was announced in 2016, shortly after Mylan agreed to pay $465 million to the U.S. Department of Justice to settle claims that it underpaid […]